Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Cholesteryl chloride is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

910-31-6

Post Buying Request

910-31-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

910-31-6 Usage

Chemical Properties

white to off-white crystalline powder

Check Digit Verification of cas no

The CAS Registry Mumber 910-31-6 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 9,1 and 0 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 910-31:
(5*9)+(4*1)+(3*0)+(2*3)+(1*1)=56
56 % 10 = 6
So 910-31-6 is a valid CAS Registry Number.
InChI:InChI=1/C27H45Cl/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h9,18-19,21-25H,6-8,10-17H2,1-5H3/t19-,21+,22+,23-,24+,25+,26+,27-/m1/s1

910-31-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (C0610)  Cholesteryl Chloride  >95.0%(GC)

  • 910-31-6

  • 25g

  • 660.00CNY

  • Detail
  • Alfa Aesar

  • (A10433)  Cholesteryl chloride, 98%   

  • 910-31-6

  • 25g

  • 559.0CNY

  • Detail
  • Alfa Aesar

  • (A10433)  Cholesteryl chloride, 98%   

  • 910-31-6

  • 100g

  • 1621.0CNY

  • Detail
  • Alfa Aesar

  • (A10433)  Cholesteryl chloride, 98%   

  • 910-31-6

  • 500g

  • 7070.0CNY

  • Detail
  • Aldrich

  • (C76604)  Cholesterylchloride  97%

  • 910-31-6

  • C76604-25G

  • 661.05CNY

  • Detail

910-31-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name Cholesteryl chloride

1.2 Other means of identification

Product number -
Other names Cholest-5-ene, 3-chloro-, (3β)-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:910-31-6 SDS

910-31-6Synthetic route

cholesterol
57-88-5

cholesterol

cholesteryl chloride
910-31-6

cholesteryl chloride

Conditions
ConditionsYield
With thionyl chloride95%
With Me2SeCl2; triphenylphosphine In benzene for 20h; Ambient temperature;84%
With 1-pyrrolidinecarboxaldehyde; 1,3,5-trichloro-2,4,6-triazine In 1,4-dioxane; chloroform at 80℃; for 4h; Solvent; Sealed tube; Green chemistry;82%
cholesteryl chloride
910-31-6

cholesteryl chloride

Conditions
ConditionsYield
With iodine; triphenylphosphine In dichloromethane95%
cholesterol mesylate
3381-54-2

cholesterol mesylate

cholesteryl chloride
910-31-6

cholesteryl chloride

Conditions
ConditionsYield
With chloro-trimethyl-silane; titanium tetrachloride In dichloromethane at -20℃; for 0.0833333h; Inert atmosphere;95%
With iron(III) chloride In dichloromethane at 20℃; for 0.0833333h; Inert atmosphere;87%
With chloro-trimethyl-silane; titanium tetrachloride In dichloromethane at -78 - 20℃; for 0.5h;400 mg
cholest-5-en-3-ol (3β)-(O-phenyl carbonothioate)
85335-71-3

cholest-5-en-3-ol (3β)-(O-phenyl carbonothioate)

cholesteryl chloride
910-31-6

cholesteryl chloride

Conditions
ConditionsYield
With tris(p-bromophenylammoniumyl) hexachloroantimonate In toluene for 0.166667h; Irradiation;92%
With tris(p-bromophenylammoniumyl) hexachloroantimonate In toluene for 0.166667h; Ambient temperature; Irradiation; other thiocarbonyl compounds; other temperature; other reaction time; radical cation fragmentation;92%
(3S,8S,9S,10R,13R,14S,17R)-5,6-dibromo-3-chloro-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthrene

(3S,8S,9S,10R,13R,14S,17R)-5,6-dibromo-3-chloro-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthrene

cholesteryl chloride
910-31-6

cholesteryl chloride

Conditions
ConditionsYield
With 1,1'-bis(trimethylsilyl)-1,1',4,4'-tetrahydro-4,4'-bipyridylidene In acetonitrile at 20℃; for 2h; Inert atmosphere;91%
With diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate; sodium carbonate In dimethyl sulfoxide at 20℃; for 1.5h; Inert atmosphere; Irradiation;90%
(3α,5α-cyclo-cholestan-6β-yl)-methyl ether
2867-93-8, 60175-48-6, 84985-77-3, 103365-95-3, 122406-68-2

(3α,5α-cyclo-cholestan-6β-yl)-methyl ether

A

Cholesteryl acetate
604-35-3

Cholesteryl acetate

B

cholesteryl chloride
910-31-6

cholesteryl chloride

C

3,5-cholestadiene
747-90-0

3,5-cholestadiene

Conditions
ConditionsYield
With hydrogenchloride In acetic acid for 3h; Ambient temperature;A 2%
B 88%
C 10%
With hydrogenchloride In acetic acid for 3h; Heating;A 30%
B 55%
C 15%
2-[(3S,8S,9S,10R,13R,14S,17R)-17-((R)-1,5-Dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yloxysulfonyl]-benzoic acid 2-(2-methoxy-ethoxy)-ethyl ester
888021-88-3

2-[(3S,8S,9S,10R,13R,14S,17R)-17-((R)-1,5-Dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yloxysulfonyl]-benzoic acid 2-(2-methoxy-ethoxy)-ethyl ester

cholesteryl chloride
910-31-6

cholesteryl chloride

Conditions
ConditionsYield
With titanium tetrachloride In dichloromethane at -78℃;85%
3β-((bromomercurio)methyl)-A,B-dinor-5β-cholestane-5-carbaldehyde
220090-37-9

3β-((bromomercurio)methyl)-A,B-dinor-5β-cholestane-5-carbaldehyde

cholesteryl chloride
910-31-6

cholesteryl chloride

Conditions
ConditionsYield
With aluminium trichloride In 1,2-dimethoxyethane at 45℃; for 18h;79%
With molybdenum(V) chloride In diethyl ether at -78℃; for 4h;79%
With molybdenum(V) chloride In diethyl ether for 2h; Ambient temperature;78%
cholesterol
57-88-5

cholesterol

A

cholesteryl chloride
910-31-6

cholesteryl chloride

B

dicholesteryl ether
2469-23-0

dicholesteryl ether

Conditions
ConditionsYield
With iron(III) chloride In dichloromethane at 20℃; for 5h;A 69%
B n/a
With silica gel; iron(III) chloride In diethyl ether; dichloromethane in column;A 52%
B 28%
silica gel; iron(III) chloride In diethyl ether; dichloromethane Product distribution;
cholesterol
57-88-5

cholesterol

A

Cholesteryl acetate
604-35-3

Cholesteryl acetate

B

cholesteryl chloride
910-31-6

cholesteryl chloride

C

3,5-cholestadiene
747-90-0

3,5-cholestadiene

Conditions
ConditionsYield
With hydrogenchloride In acetic acid for 3h; Heating;A 65%
B 12%
C 23%
With hydrogenchloride In acetic acid for 2h; Heating;A 65%
B 12%
C 23%
O-((3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl) S-methyl carbonodithioate
53496-46-1

O-((3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl) S-methyl carbonodithioate

cholesteryl chloride
910-31-6

cholesteryl chloride

Conditions
ConditionsYield
With sulfuryl dichloride In tetrachloromethane 1.) 0 deg C, 3 h, 2.) 7 h, room temperature;62%
With tetrachloromethane Irradiation; 254 nm light;
With tris(p-bromophenylammoniumyl) hexachloroantimonate In toluene at 110℃; for 0.5h; Irradiation;
cholesteryl p-toluenesulfonate
1182-65-6, 3381-56-4

cholesteryl p-toluenesulfonate

cholesteryl chloride
910-31-6

cholesteryl chloride

Conditions
ConditionsYield
With 1-butyl-3-methylimidazolium chloride In acetonitrile at 60℃; for 24h; Inert atmosphere; Green chemistry;60%
cholesterol mesylate
3381-54-2

cholesterol mesylate

A

cholesteryl chloride
910-31-6

cholesteryl chloride

B

3β-azido-cholest-5-ene
1433-82-5

3β-azido-cholest-5-ene

Conditions
ConditionsYield
With aluminum (III) chloride; trimethylsilylazide In dichloromethane at 22℃; for 1h; Inert atmosphere;A 34%
B 57%
6β-phenylsulfanyl-3α,5α-cyclocholestane
79327-32-5

6β-phenylsulfanyl-3α,5α-cyclocholestane

1,2:3,4-di-O-isopropylidene-α-D-galactopyranose
4064-06-6

1,2:3,4-di-O-isopropylidene-α-D-galactopyranose

A

3β-O-(1’,2’:3’,4’-di-O-isopropylidene-α-D-galactopyranos-6’-yl)cholest-5-ene
1232680-84-0

3β-O-(1’,2’:3’,4’-di-O-isopropylidene-α-D-galactopyranos-6’-yl)cholest-5-ene

B

cholesterol
57-88-5

cholesterol

C

Cholest-5-en-3-one
601-54-7

Cholest-5-en-3-one

D

6β-O-(1',2':3',4'-di-O-isopropylidene-α-D-galactopyranos-6'-yl)-3α,5α-cyclocholestane
1456599-12-4

6β-O-(1',2':3',4'-di-O-isopropylidene-α-D-galactopyranos-6'-yl)-3α,5α-cyclocholestane

E

cholesteryl chloride
910-31-6

cholesteryl chloride

F

3,5-cholestadiene
747-90-0

3,5-cholestadiene

G

diphenyldisulfane
882-33-7

diphenyldisulfane

Conditions
ConditionsYield
With tetrabutylammonium tetrafluoroborate In dichloromethane for 2h; Electrochemical reaction;A 40%
B n/a
C n/a
D n/a
E n/a
F n/a
G n/a
cholesterol
57-88-5

cholesterol

A

Cholesteryl acetate
604-35-3

Cholesteryl acetate

B

N-acetyl-cholest-5-en-3β-amine
14412-92-1

N-acetyl-cholest-5-en-3β-amine

C

cholesteryl chloride
910-31-6

cholesteryl chloride

D

dicholesteryl ether
2469-23-0

dicholesteryl ether

Conditions
ConditionsYield
With tetrabutylammonium tetrafluoroborate; acetic acid In dichloromethane Electrochemical reaction; separated electrodes;A 4%
B 4%
C 3%
D 28%
Cholesteryl acetate
604-35-3

Cholesteryl acetate

A

cholesteryl chloride
910-31-6

cholesteryl chloride

B

3,5-cholestadiene
747-90-0

3,5-cholestadiene

Conditions
ConditionsYield
With hydrogenchloride In acetic acid for 3h; Heating;A 11%
B 23%
With hydrogenchloride In acetic acid for 2h; Heating;A 11%
B 23%
chloroform
67-66-3

chloroform

6β-chloro-3α,5α-cyclo-cholestane
14026-00-7, 33179-23-6, 122330-89-6, 122330-90-9

6β-chloro-3α,5α-cyclo-cholestane

cholesteryl chloride
910-31-6

cholesteryl chloride

cholesterol
57-88-5

cholesterol

cholesteryl chloride
910-31-6

cholesteryl chloride

Conditions
ConditionsYield
With phosphorus pentachloride
With thionyl chloride
With trichlorophosphate
3β-chloro-6β-hydroxy-5α-cholestane
78425-50-0

3β-chloro-6β-hydroxy-5α-cholestane

cholesteryl chloride
910-31-6

cholesteryl chloride

Conditions
ConditionsYield
With pyridine; trichlorophosphate
3α,5α-cyclo-cholest-6-ene
3381-57-5, 35868-81-6

3α,5α-cyclo-cholest-6-ene

cholesteryl chloride
910-31-6

cholesteryl chloride

Conditions
ConditionsYield
With hydrogenchloride; acetone
With hydrogenchloride; acetone
3β-chloro-5.6β-dibromo-5α-cholestane
5337-45-1

3β-chloro-5.6β-dibromo-5α-cholestane

sodium ethanolate
141-52-6

sodium ethanolate

cholesteryl chloride
910-31-6

cholesteryl chloride

3β-chloro-5,6α-epoxy-5α-cholestane
13095-30-2

3β-chloro-5,6α-epoxy-5α-cholestane

cholesteryl chloride
910-31-6

cholesteryl chloride

Conditions
ConditionsYield
With aluminum oxide; silver nitrate In diethyl ether Ambient temperature; Yield given;
3β-chloro-5.6β-dibromo-5α-cholestane
5337-45-1

3β-chloro-5.6β-dibromo-5α-cholestane

cholesteryl chloride
910-31-6

cholesteryl chloride

Conditions
ConditionsYield
With sodium tetrahydroborate; nickel dichloride In N,N-dimethyl-formamide for 0.25h; Yield given;
thionyl chloride
7719-09-7

thionyl chloride

cholesterol
57-88-5

cholesterol

cholesteryl chloride
910-31-6

cholesteryl chloride

cholesterol
57-88-5

cholesterol

PCl5 (2 mol)

PCl5 (2 mol)

A

cholesteryl chloride
910-31-6

cholesteryl chloride

B

3.3-dichloro-cholestene-(5)

3.3-dichloro-cholestene-(5)

3α.5-cyclo-5α-cholestanol-(6α)

3α.5-cyclo-5α-cholestanol-(6α)

cholesteryl chloride
910-31-6

cholesteryl chloride

Conditions
ConditionsYield
With hydrogenchloride
With hydrogenchloride; acetic acid
3α.5-cyclo-5α-cholestanol-(6β)

3α.5-cyclo-5α-cholestanol-(6β)

cholesteryl chloride
910-31-6

cholesteryl chloride

Conditions
ConditionsYield
With hydrogenchloride
With hydrogenchloride; acetic acid
6β-methoxy-3α.5-cyclo-5α-cholestane

6β-methoxy-3α.5-cyclo-5α-cholestane

cholesteryl chloride
910-31-6

cholesteryl chloride

Conditions
ConditionsYield
With hydrogenchloride
With hydrogenchloride; acetic acid
O-chloroformyl-cholesterol

O-chloroformyl-cholesterol

cholesteryl chloride
910-31-6

cholesteryl chloride

3β-chloro-5.6β-dibromo-5α-cholestane
5337-45-1

3β-chloro-5.6β-dibromo-5α-cholestane

aqueous KOH

aqueous KOH

cholesteryl chloride
910-31-6

cholesteryl chloride

cholesteryl chloride
910-31-6

cholesteryl chloride

cholest-5-ene
570-74-1

cholest-5-ene

Conditions
ConditionsYield
With N,N,N,N,N,N-hexamethylphosphoric triamide; samarium diiodide; isopropyl alcohol In tetrahydrofuran for 3h; Ambient temperature;99%
With sodium In tetrahydrofuran; tert-butyl alcohol for 24h; Inert atmosphere; Reflux;84%
With potassium Sodium; tert-butyl alcohol; Tris(3,6-dioxaheptyl)amine In tetrahydrofuran Ambient temperature; var. cat.: 18-crown-6;81%
cholesteryl chloride
910-31-6

cholesteryl chloride

3β-chlorocholest-5-en-7-one
55105-71-0

3β-chlorocholest-5-en-7-one

Conditions
ConditionsYield
With tert.-butylhydroperoxide; [copper(II)(salqu)] In acetonitrile at 70℃;99%
With tert.-butylhydroperoxide; [bis(acetoxy)iodo]benzene; magnesium acetate tetrahydrate In decane; butyl butyrate at 0℃; for 6h; regioselective reaction;85%
With potassium dichromate; 1-hydroxy-pyrrolidine-2,5-dione; acetic acid In acetone at 40℃; for 18h; Inert atmosphere;78%
cholesteryl chloride
910-31-6

cholesteryl chloride

(3S,8S,9S,10R,13R,14S,17R)-5,6-dibromo-3-chloro-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthrene

(3S,8S,9S,10R,13R,14S,17R)-5,6-dibromo-3-chloro-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthrene

Conditions
ConditionsYield
With bromine In tetrachloromethane at -20 - 20℃;99%
With bromine In tetrachloromethane at 0 - 20℃; for 12.1667h;
cholesteryl chloride
910-31-6

cholesteryl chloride

3β-chloro-5α-cholestane
1474-58-4

3β-chloro-5α-cholestane

Conditions
ConditionsYield
With hydrogen; palladium diacetate In ethanol at 20℃;95%
With 10% palladium on carbon; hydrogen In diethyl ether for 4h;94%
With diethyl ether; ethanol; platinum Hydrogenation;
cholesteryl chloride
910-31-6

cholesteryl chloride

Conditions
ConditionsYield
With Rf2Bimpy; oxygen; isobutyraldehyde; ruthenium trichloride In chlorobenzene; acetone at 40℃; under 760 Torr; for 2.5h;94%
With perfluoro-cis-2-n-butyl-3-n-propyloxaziridine In chloroform at -10℃; for 0.5h;92%
With methyl hexanoate; CpLIP2 Y179F (ipase/acyltransferase) from Candida parapsilosis; dihydrogen peroxide In aq. phosphate buffer; water at 20℃; pH=6.5; Enzymatic reaction;59%
cholesteryl chloride
910-31-6

cholesteryl chloride

3β-chloro-5,6α-epoxy-5α-cholestane
13095-30-2

3β-chloro-5,6α-epoxy-5α-cholestane

Conditions
ConditionsYield
With 3-chloro-benzenecarboperoxoic acid In chloroform at 20℃; for 27.5h; Epoxidation;92%
cholesteryl chloride
910-31-6

cholesteryl chloride

N,N-dimethyl-formamide
68-12-2, 33513-42-7

N,N-dimethyl-formamide

cholesteryl formate
4351-55-7

cholesteryl formate

Conditions
ConditionsYield
With silver tetrafluoroborate In nitromethane at 40℃; for 12h;92%
cholesteryl chloride
910-31-6

cholesteryl chloride

3β-chloro-5.6β-dibromo-5α-cholestane
5337-45-1

3β-chloro-5.6β-dibromo-5α-cholestane

Conditions
ConditionsYield
With tetraethylammonium bromide In dichloromethane at 20℃; for 0.5h; Electrochemical reaction;91%
2,3-dimethyl-2,3-butane diol
76-09-5

2,3-dimethyl-2,3-butane diol

cholesteryl chloride
910-31-6

cholesteryl chloride

benzo[1,3,2]dioxaborole
274-07-7

benzo[1,3,2]dioxaborole

2-((3S,6S,8R,9S,10S,13R,14S,17R)-3-chloro-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-((3S,6S,8R,9S,10S,13R,14S,17R)-3-chloro-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Conditions
ConditionsYield
Stage #1: cholesteryl chloride; benzo[1,3,2]dioxaborole at 100℃; for 16h; Inert atmosphere; Schlenk technique;
Stage #2: 2,3-dimethyl-2,3-butane diol With triethylamine In dichloromethane at 0℃; Inert atmosphere; Schlenk technique;
86%
cholesteryl chloride
910-31-6

cholesteryl chloride

acetic acid
64-19-7

acetic acid

Cholesteryl acetate
604-35-3

Cholesteryl acetate

Conditions
ConditionsYield
With zinc for 1h; Heating;85%
cholesteryl chloride
910-31-6

cholesteryl chloride

3β-azido-cholest-5-ene
1433-82-5

3β-azido-cholest-5-ene

Conditions
ConditionsYield
With sodium azide In N,N-dimethyl-formamide at 100℃;83%
With trimethylsilylazide; tin(IV) chloride In dichloromethane at -20 - 22℃; for 3h; Inert atmosphere;50%
ethanol
64-17-5

ethanol

cholesteryl chloride
910-31-6

cholesteryl chloride

3-ethylcholesterol
986-19-6

3-ethylcholesterol

Conditions
ConditionsYield
With zinc(II) chloride In toluene at 77℃; for 20h;80%
cholesteryl chloride
910-31-6

cholesteryl chloride

3β-chloro-5-iodo-5α-cholestan-6-one

3β-chloro-5-iodo-5α-cholestan-6-one

Conditions
ConditionsYield
With pyridine; silver(I) chromate; iodine In dichloromethane 1.) 0 deg C, 20 min, 2.) room temperature, 1 h.;78%
propan-1-ol
71-23-8

propan-1-ol

cholesteryl chloride
910-31-6

cholesteryl chloride

cholesterol propyl ether
10322-02-8

cholesterol propyl ether

Conditions
ConditionsYield
With zinc(II) chloride In water at 97℃; for 5h;75%
cholesteryl chloride
910-31-6

cholesteryl chloride

3β-chloro-6-nitrocholest-4-ene

3β-chloro-6-nitrocholest-4-ene

Conditions
ConditionsYield
With ammonium cerium(IV) nitrate; sodium nitrite In acetonitrile at 50℃;74%
cholesteryl chloride
910-31-6

cholesteryl chloride

(3S,8S,9S,10R,13R,14S,17R)-3-Chloro-17-((R)-1,5-dimethyl-hexyl)-10,13-dimethyl-6-nitrooxy-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene

(3S,8S,9S,10R,13R,14S,17R)-3-Chloro-17-((R)-1,5-dimethyl-hexyl)-10,13-dimethyl-6-nitrooxy-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene

Conditions
ConditionsYield
With ammonium cerium(IV) nitrate In acetonitrile Heating;73%
methanol
67-56-1

methanol

cholesteryl chloride
910-31-6

cholesteryl chloride

cholesteryl methyl ether
1174-92-1

cholesteryl methyl ether

Conditions
ConditionsYield
With zinc(II) chloride In toluene at 64℃; for 32h;70%
at 125℃;
cholesteryl chloride
910-31-6

cholesteryl chloride

3β,5α-dichloro-6β-nitrocholestane
15505-92-7

3β,5α-dichloro-6β-nitrocholestane

Conditions
ConditionsYield
With acetyl chloride; sodium nitrite In dichloromethane at 25℃; for 4h; Nitration; Addition;70%
With chloro-trimethyl-silane; sodium nitrite In dichloromethane; chloroform Ambient temperature;65%
With potassium acetate; nitrosylchloride In diethyl ether
With nitrosylchloride In tetrachloromethane at 0℃; for 2h;1.5 g
methanol
67-56-1

methanol

cholesteryl chloride
910-31-6

cholesteryl chloride

A

6β-bromo-3β-chloro-5α-methoxycholestane

6β-bromo-3β-chloro-5α-methoxycholestane

B

5α-bromo-3β-chloro-6β-methoxycholestane

5α-bromo-3β-chloro-6β-methoxycholestane

C

3β-chloro-5.6β-dibromo-5α-cholestane
5337-45-1

3β-chloro-5.6β-dibromo-5α-cholestane

Conditions
ConditionsYield
With tetraethylammonium bromide at 55℃; for 0.5h; Electrochemical reaction;A n/a
B n/a
C 66%
cholesteryl chloride
910-31-6

cholesteryl chloride

butan-1-ol
71-36-3

butan-1-ol

n-butyl cholesteryl ether
10322-03-9

n-butyl cholesteryl ether

Conditions
ConditionsYield
With zinc(II) chloride In water at 100℃; for 4h;65%

910-31-6Relevant articles and documents

Regioselective opening of a cyclopropane ring by mercury(II) and transmetalation of the product with molybdenum. A novel, stereoelectronically controlled, skeletal rearrangement ans Grob-type fragmentation of organomolybdenum intermediates

Srogl, Jiri,Kocovsky, Pavel

, p. 5991 - 5994 (1992)

Organomercurial 2, arising by a regioselective ring-opening of cyclopropane derivative 1, can be transmetalated with Mo-reagents to initially generate complexes 3 and 7. While 3 reacts further via a stereoelectronically controlled cascade rearrangement to afford 6, complex 7 favors a Grob-type fragmentation leading to 9.

Novel synthesis of 5-hydroxy-5α-cholesta-2,7-dien-6-one and its criegee hydroxylation

Kovganko,Sokolov

, p. 590 - 594 (2000)

Cholesterol (1) is used to synthesize again 5α-hydroxy-2,7-dien-6-one (5) through the intermediates 2-4. cis-Hydroxylation of 5 with OsO4 and subsequent acetylation give steroids 6-8. Dehydration of 5α-hydroxy-6-ketone 6 forms the unsaturated compounds 9-11.

A mild method for the replacement of a hydroxyl group by halogen: 2. unified procedure and stereochemical studies

Gati, Wafa,Munyemana, Fran?ois,Colens, Alain,Srour, Aladdin,Dufour, Mathilde,Vardhan Reddy, K. Harsha,Téchy, Brigitte,Rosse, Gérard,Schweiger, Ed,Qiao, Qi,Ghosez, Léon

, (2020/08/19)

N,N-Dimethyl- and N,N-diisopropyl-1-halo-2-methyl-l-propenylamines are readily available reagents for the mild deoxyhalogenation of alcohols and hydroxyacids. In this study we showed that the reactivity of the reagents can be tuned by varying the size of the alkyl groups on the reagents: the replacement of methyl by isopropyl groups led to a significant increase of reactivity. We then described a unified procedure for all deoxyhalogenations using the readily available α-chloroenamines as reagents with (bromination, iodination) or without (chlorination) an alkaline bromide or iodide. Finally, we showed that deoxyhalogenation reactions of secondary alcohols were highly stereospecific and generally occurred with inversion of configuration.

A General Catalytic Method for Highly Cost- and Atom-Efficient Nucleophilic Substitutions

Huy, Peter H.,Filbrich, Isabel

supporting information, p. 7410 - 7416 (2018/04/30)

A general formamide-catalyzed protocol for the efficient transformation of alcohols into alkyl chlorides, which is promoted by substoichiometric amounts (down to 34 mol %) of inexpensive trichlorotriazine (TCT), is introduced. This is the first example of a TCT-mediated dihydroxychlorination of an OH-containing substrate (e.g., alcohols and carboxylic acids) in which all three chlorine atoms of TCT are transferred to the starting material. The consequently enhanced atom economy facilitates a significantly improved waste balance (E-factors down to 4), cost efficiency, and scalability (>50 g). Furthermore, the current procedure is distinguished by high levels of functional-group compatibility and stereoselectivity, as only weakly acidic cyanuric acid is released as exclusive byproduct. Finally, a one-pot protocol for the preparation of amines, azides, ethers, and sulfides enabled the synthesis of the drug rivastigmine with twofold SN2 inversion, which demonstrates the high practical value of the presented method.

Ti-Catalyzed Radical Alkylation of Secondary and Tertiary Alkyl Chlorides Using Michael Acceptors

Wu, Xiangyu,Hao, Wei,Ye, Ke-Yin,Jiang, Binyang,Pombar, Gisselle,Song, Zhidong,Lin, Song

, p. 14836 - 14843 (2018/11/10)

Alkyl chlorides are common functional groups in synthetic organic chemistry. However, the engagement of unactivated alkyl chlorides, especially tertiary alkyl chlorides, in transition-metal-catalyzed C-C bond formation remains challenging. Herein, we describe the development of a TiIII-catalyzed radical addition of 2° and 3° alkyl chlorides to electron-deficient alkenes. Mechanistic data are consistent with inner-sphere activation of the C-Cl bond featuring TiIII-mediated Cl atom abstraction. Evidence suggests that the active TiIII catalyst is generated from the TiIV precursor in a Lewis-acid-assisted electron transfer process.

Dehalogenation of vicinal dihalo compounds by 1,1′-bis(trimethylsilyl)-1: H,1′ H-4,4′-bipyridinylidene for giving alkenes and alkynes in a salt-free manner

Rej, Supriya,Pramanik, Suman,Tsurugi, Hayato,Mashima, Kazushi

supporting information, p. 13157 - 13160 (2017/12/26)

We report a transition metal-free dehalogenation of vicinal dihalo compounds by 1,1′-bis(trimethylsilyl)-1H,1′H-4,4′-bipyridinylidene (1) under mild conditions, in which trimethylsilyl halide and 4,4′-bipyridine were generated as byproducts. The synthetic protocol for this dehalogenation reaction was effective for a wide scope of dibromo compounds as substrates while keeping the various functional groups intact. Furthermore, the reduction of vicinal dichloro alkanes and vicinal dibromo alkenes also proceeded in a salt-free manner to afford the corresponding alkenes and alkynes.

METHOD OF CONVERTING ALCOHOL TO HALIDE

-

Page/Page column 51; 181, (2017/01/02)

The present invention relates to a method of converting an alcohol into a corresponding halide. This method comprises reacting the alcohol with an optionally substituted aromatic carboxylic acid halide in presence of an N-substituted formamide to replace a hydroxyl group of the alcohol by a halogen atom. The present invention also relates to a method of converting an alcohol into a corresponding substitution product. The second method comprises: (a) performing the method of the invention of converting an alcohol into the corresponding halide; and (b) reacting the corresponding halide with a nucleophile to convert the halide into the nucleophilic substitution product.

Formamides as Lewis Base Catalysts in SNReactions—Efficient Transformation of Alcohols into Chlorides, Amines, and Ethers

Huy, Peter H.,Motsch, Sebastian,Kappler, Sarah M.

supporting information, p. 10145 - 10149 (2016/08/16)

A simple formamide catalyst facilitates the efficient transformation of alcohols into alkyl chlorides with benzoyl chloride as the sole reagent. These nucleophilic substitutions proceed through iminium-activated alcohols as intermediates. The novel method, which can be even performed under solvent-free conditions, is distinguished by an excellent functional group tolerance, scalability (>100 g) and waste-balance (E-factor down to 2). Chiral substrates are converted with excellent levels of stereochemical inversion (99 %→≥95 % ee). In a practical one-pot procedure, the primary formed chlorides can be further transformed into amines, azides, ethers, sulfides, and nitriles. The value of the method was demonstrated in straightforward syntheses of the drugs rac-Clopidogrel and S-Fendiline.

Hantzsch Ester as a Photosensitizer for the Visible-Light-Induced Debromination of Vicinal Dibromo Compounds

Chen, Wenxin,Tao, Huachen,Huang, Wenhao,Wang, Guoqiang,Li, Shuhua,Cheng, Xu,Li, Guigen

supporting information, p. 9546 - 9550 (2016/07/14)

The debromination of vicinal dibromo compounds to generate alkenes usually requires harsh reaction conditions and the addition of catalysts. Just recently the visible-light-induced debromination of vicinal dibromo compounds emerged as a possible alternative to commonly used methods, but the substrate scope of this reaction is limited and a photocatalyst is necessary for the successful conversion of the starting compounds. A catalyst-free visible-light-induced debromination of vicinal dibromo compounds with a base-activated Hantzsch ester as photosensitizer is reported. The method has a wide substrate scope and a broad functional-group compatibility.

Synthesis and characterization of steroidal heterocyclic compounds, DNA condensation and molecular docking studies and their in vitro anticancer and acetylcholinesterase inhibition activities

Ali, Abad,Asif, Mohd,Khanam, Hena,Mashrai, Ashraf,Sherwani, Mohd Asif,Owais, Mohammad,Shamsuzzaman

, p. 75964 - 75984 (2015/09/28)

A facile, convenient and efficient approach for the synthesis of a new series of steroidal heterocyclic compounds (4-12) by reacting a mixture of compounds (1e-3e) with o-aminothiophenol/o-aminophenol/o-phenylenediamine is reported. The structural assignment of products is confirmed on the basis of IR, 1H NMR, 13C NMR, MS and analytical data. The compounds obey the Lipinski's 'Rule of Five' analysis based on computational prediction and pharmacokinetic properties. The anticancer activity has been tested in vitro against three cancer cell lines Hep3B (human hepatocellular carcinoma), MCF7 (human breast adenocarcinoma), HeLa (human cervical carcinoma) and one non-cancer normal cell i.e. PBMCs (peripheral blood mononuclear cell) by MTT assay. In addition, the synthesized compounds are also tested for their in vitro antioxidant activity by various reported methods in which compounds 10-12 exhibited good antioxidant activity. Nonenzymatic degradation of DNA has been investigated. The acetylcholinesterase (AChE) inhibitor activities of the steroidal derivatives are also evaluated using Ellman's method. Moreover, the application of compound 6 as a DNA gene transporter is evaluated by DNA condensation and ascertained by employing TEM and AFM, which illustrate that the compound 6 induces the condensation of CT-DNA. Molecular docking studies further characterize the interaction of the synthesized compounds with DNA. 2015

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 910-31-6